601 related articles for article (PubMed ID: 27131608)
1. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles.
Malinovskaja-Gomez K; Labouta HI; Schneider M; Hirvonen J; Laaksonen T
Eur J Pharm Sci; 2016 Jun; 89():154-62. PubMed ID: 27131608
[TBL] [Abstract][Full Text] [Related]
2. Iontophoretic transdermal delivery using chitosan-coated PLGA nanoparticles for positively charged drugs.
Takeuchi I; Takeshita T; Suzuki T; Makino K
Colloids Surf B Biointerfaces; 2017 Dec; 160():520-526. PubMed ID: 29017147
[TBL] [Abstract][Full Text] [Related]
3. Enhanced transdermal delivery of indomethacin using combination of PLGA nanoparticles and iontophoresis in vivo.
Tomoda K; Terashima H; Suzuki K; Inagi T; Terada H; Makino K
Colloids Surf B Biointerfaces; 2012 Apr; 92():50-4. PubMed ID: 22154100
[TBL] [Abstract][Full Text] [Related]
4. Enhanced transdermal delivery of indomethacin-loaded PLGA nanoparticles by iontophoresis.
Tomoda K; Terashima H; Suzuki K; Inagi T; Terada H; Makino K
Colloids Surf B Biointerfaces; 2011 Dec; 88(2):706-10. PubMed ID: 21885261
[TBL] [Abstract][Full Text] [Related]
5. Comparison of liposomal drug formulations for transdermal iontophoretic drug delivery.
Malinovskaja-Gomez K; Espuelas S; Garrido MJ; Hirvonen J; Laaksonen T
Eur J Pharm Sci; 2017 Aug; 106():294-301. PubMed ID: 28625748
[TBL] [Abstract][Full Text] [Related]
6. Enhanced transdermal permeability of estradiol using combination of PLGA nanoparticles system and iontophoresis.
Tomoda K; Watanabe A; Suzuki K; Inagi T; Terada H; Makino K
Colloids Surf B Biointerfaces; 2012 Sep; 97():84-9. PubMed ID: 22609586
[TBL] [Abstract][Full Text] [Related]
7. Influence of nanoencapsulation on human skin transport of flufenamic acid.
Luengo J; Weiss B; Schneider M; Ehlers A; Stracke F; König K; Kostka KH; Lehr CM; Schaefer UF
Skin Pharmacol Physiol; 2006; 19(4):190-7. PubMed ID: 16679821
[TBL] [Abstract][Full Text] [Related]
8. Transdermal delivery of estradiol-loaded PLGA nanoparticles using iontophoresis for treatment of osteoporosis.
Takeuchi I; Fukuda K; Kobayashi S; Makino K
Biomed Mater Eng; 2016 Nov; 27(5):475-483. PubMed ID: 27885995
[TBL] [Abstract][Full Text] [Related]
9. Skin permeability and transdermal delivery route of 50-nm indomethacin-loaded PLGA nanoparticles.
Takeuchi I; Suzuki T; Makino K
Colloids Surf B Biointerfaces; 2017 Nov; 159():312-317. PubMed ID: 28858661
[TBL] [Abstract][Full Text] [Related]
10. Comparison of PLGA and lecithin/chitosan nanoparticles for dermal targeting of betamethasone valerate.
Özcan I; Azizoğlu E; Senyiğit T; Özyazici M; Özer Ö
J Drug Target; 2013 Jul; 21(6):542-50. PubMed ID: 23390922
[TBL] [Abstract][Full Text] [Related]
11. Iontophoretic delivery of lipophilic and hydrophilic drugs from lipid nanoparticles across human skin.
Charoenputtakun P; Li SK; Ngawhirunpat T
Int J Pharm; 2015 Nov; 495(1):318-328. PubMed ID: 26325320
[TBL] [Abstract][Full Text] [Related]
12. Estradiol-loaded PLGA nanoparticles for improving low bone mineral density of cancellous bone caused by osteoporosis: Application of enhanced charged nanoparticles with iontophoresis.
Takeuchi I; Kobayashi S; Hida Y; Makino K
Colloids Surf B Biointerfaces; 2017 Jul; 155():35-40. PubMed ID: 28391082
[TBL] [Abstract][Full Text] [Related]
13. Development of transdermal vitamin D3 (VD3) delivery system using combinations of PLGA nanoparticles and microneedles.
Kim HG; Gater DL; Kim YC
Drug Deliv Transl Res; 2018 Feb; 8(1):281-290. PubMed ID: 29247316
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
[TBL] [Abstract][Full Text] [Related]
15. Controlled transdermal delivery of leuprorelin by pulsed iontophoresis and ion-exchange fiber.
Malinovskaja K; Laaksonen T; Hirvonen J
Eur J Pharm Biopharm; 2014 Nov; 88(3):594-601. PubMed ID: 25173088
[TBL] [Abstract][Full Text] [Related]
16. Microneedle/nanoencapsulation-mediated transdermal delivery: mechanistic insights.
Gomaa YA; Garland MJ; McInnes FJ; Donnelly RF; El-Khordagui LK; Wilson CG
Eur J Pharm Biopharm; 2014 Feb; 86(2):145-55. PubMed ID: 23461860
[TBL] [Abstract][Full Text] [Related]
17. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
[TBL] [Abstract][Full Text] [Related]
18. Transdermal iontophoretic drug delivery: advances and challenges.
Ita K
J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291
[TBL] [Abstract][Full Text] [Related]
19. Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles.
Zhang W; Gao J; Zhu Q; Zhang M; Ding X; Wang X; Hou X; Fan W; Ding B; Wu X; Wang X; Gao S
Int J Pharm; 2010 Dec; 402(1-2):205-12. PubMed ID: 20932886
[TBL] [Abstract][Full Text] [Related]
20. Hybrid poly(lactic-co-glycolic acid) nanoparticles: design and delivery prospectives.
Pandita D; Kumar S; Lather V
Drug Discov Today; 2015 Jan; 20(1):95-104. PubMed ID: 25277320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]